Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	80348
Country	Mexico

Received	2022-09-24 01:46
Peer-Review Started	2022-09-24 01:47
To Make the First Decision
Return for Revision	2022-10-20 14:30
Revised	2022-11-03 10:16
Second Decision	2023-01-10 03:34
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2023-01-10 18:15
Articles in Press	2023-01-10 18:15
Publication Fee Transferred
Edit the Manuscript by Language Editor	2022-12-26 23:45
Typeset the Manuscript	2023-02-07 06:41
Publish the Manuscript Online	2023-02-15 00:44

ISSN	1948-5204 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Immunology
Manuscript Type	Review
Article Title	Is the combination of immunotherapy with conventional chemotherapy the key to increase the efficacy of colorectal cancer treatment?
Manuscript Source	Invited Manuscript
All Author List	Jonadab E Olguin, Monica G Mendoza-Rodriguez, C Angel Sanchez-Barrera and Luis I Terrazas
ORCID	Author(s) ORCID Number Luis I Terrazas http://orcid.org/0000-0003-4649-4117
Funding Agency and Grant Number
Corresponding Author	Luis I Terrazas, PhD, Chairman, Senior Scientist, Unidad de Biomedicina, Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México, Avenida de los Barrios # 1, Tlalnepantla 54090, Estado de Mexico, Mexico. literrazas@unam.mx
Key Words	Colorectal cancer; Immunotherapy checkpoint inhibitors; Chemotherapy; Immunotherapy; Immune response
Core Tip	This review focused on the drugs that may modulate the immune response and show specific efficacy in the treatment of colorectal cancer. We then presented the evidence that immunosuppression or promotion of the immune response is the answer to generating effective treatments with combined chemotherapeutic drugs.
Publish Date	2023-02-15 00:44
Citation	Olguin JE, Mendoza-Rodriguez MG, Sanchez-Barrera CA, Terrazas LI. Is the combination of immunotherapy with conventional chemotherapy the key to increase the efficacy of colorectal cancer treatment? . World J Gastrointest Oncol 2023; 15(2): 251-267
URL	https://www.wjgnet.com/1948-5204/full/v15/i2/251.htm
DOI	https://dx.doi.org/10.4251/wjgo.v15.i2.251

Full Article (PDF)	WJGO-15-251.pdf
Full Article (Word)	WJGO-15-251.docx
Manuscript File	80348_Auto_edited-LM.docx
Answering Reviewers	80348-Answering reviewers.pdf
Audio Core Tip	80348-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	80348-Conflict-of-interest statement.pdf
Copyright License Agreement	80348-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	80348-Language certificate.pdf
Peer-review Report	80348-Peer-review(s).pdf
Scientific Misconduct Check	80348-Bing-Gao CC-2.png
Scientific Editor Work List	80348-Scientific editor work list.pdf